Skip to main content
Global Bioenergies logo

Global Bioenergies — Investor Relations & Filings

Ticker · ALGBE ISIN · FR0011052257 LEI · 969500H46XRAMTMVB676 PA Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2025-03-19 Regulatory Filings
Country FR France
Listing PA ALGBE

About Global Bioenergies

https://www.global-bioenergies.com/?lan…

Global Bioenergies develops and commercializes a process to convert renewable resources, such as plant-based sugars and agricultural waste, into isobutene. The company's proprietary technology utilizes fermentation and synthetic biology to produce this key hydrocarbon, which serves as a platform molecule for various applications. The bio-isobutene can be converted into ingredients for the cosmetics industry, specialty chemicals, and renewable fuels. A primary strategic focus is the production of Sustainable Aviation Fuel (SAF) to support the decarbonization of the aviation sector. The process provides a bio-based alternative to petroleum-derived hydrocarbons, aiming to reduce CO2 emissions and dependence on fossil fuels.

Recent filings

Filing Released Lang Actions
Confirmation de la performance du carburant d’aviation durable de Global Bioenergies : réalisation d’une campagne de tests d’injection et de combustion
Regulatory Filings Classification · 97% confidence The document is titled 'COMMUNIQUE DE PRESSE' (Press Release) and details recent technical testing results (injection and combustion tests) concerning Global Bioenergies' Sustainable Aviation Fuel (SAF) conducted in collaboration with Safran and ONERA. It announces positive performance data (e.g., 40-99% reduction in soot emissions) and concludes with company background and contact information. This format is characteristic of an initial announcement of significant operational or technical progress, rather than a comprehensive periodic financial report (like 10-K or IR) or a formal regulatory filing. Since it is an announcement of results/progress, it fits best under 'Earnings Release' (ER) if it were financial, but since it is technical/operational progress, and given the available options, it is a general corporate announcement. However, press releases announcing significant operational milestones or technical validations often serve the function of an Earnings Release or a general corporate update. Given the options, and recognizing this is a news announcement about technical validation supporting future commercialization, it is closest to an Earnings Release (ER) which often includes operational highlights, or potentially a Regulatory Filing (RNS) if it were a mandatory disclosure. Since it is a proactive press release detailing performance validation, and not a formal financial report, 'ER' is often used for major operational updates, but 'RNS' is the general regulatory/news fallback. Given the content is a 'COMMUNIQUE DE PRESSE' announcing technical validation, and it is not a formal financial report, 'RNS' (Regulatory Filings / General regulatory announcements) is the most appropriate general category for non-standard, non-financial press releases, although 'ER' covers initial results announcements. I will classify it as RNS as it is a general press release about technical validation, not strictly financial earnings.
2025-03-19 French
Performance of Global Bioenergies' sustainable aviation fuel confirmed: injection and combustion tests carried out
Regulatory Filings Classification · 95% confidence The document is explicitly titled "PRESS RELEASE" and details recent technical testing results (injection and combustion tests) concerning the company's Sustainable Aviation Fuel (SAF) conducted with partners like Safran and ONERA. It announces new findings regarding soot emission reduction. This format—a formal announcement of recent operational or technical achievements, often released to the public and media—is characteristic of an Earnings Release (ER) if it were tied to a financial period, or more generally, a Regulatory Filing (RNS) if it doesn't fit a specific financial report type. Since it is not a full financial report (10-K, IR), a management discussion (MDA), or a call transcript (CT), and it is a specific, non-standard announcement, it fits best as a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if these technical updates are part of a regular reporting cycle. Given the focus is purely on technical validation and not quarterly financial performance highlights, RNS is the most appropriate general category for a non-standard press release.
2025-03-19 English
Global Bioenergies publie son Document d’enregistrement universel 2024
Report Publication Announcement Classification · 98% confidence The document is a very short announcement (1776 characters) dated March 17, 2025, titled "Global Bioenergies publie son Document d'enregistrement universel 2024" (Global Bioenergies publishes its 2024 Universal Registration Document). The text explicitly states that the document has been 'publiée' (published) and is available on the company website. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report has been published, without containing the full report content, should be classified as a Report Publication Announcement (RPA). The French term 'Document d'enregistrement universel' is analogous to a comprehensive annual filing, but this document is merely the announcement of its release.
2025-03-17 French
DEU 2024 GLOBAL BIOENERGIES
Annual Report Classification · 100% confidence The document is explicitly titled 'DOCUMENT D'ENREGISTREMENT UNIVERSEL' (Universal Registration Document) for Global Bioenergies SA for the fiscal year 2024. It includes the annual financial report, management report, and consolidated financial statements. In the context of European financial reporting, a Universal Registration Document (URD) serves as the equivalent of an Annual Report (10-K equivalent). FY 2024
2025-03-14 French
Correction: Comptes annuels 2024 : forte réduction de la perte nette
Earnings Release Classification · 95% confidence The document is a press release titled 'COMMUNIQUE DE PRESSE' regarding 'Comptes annuels 2024' (2024 Annual Accounts). It provides a summary of financial highlights, including income statements, balance sheets, and management commentary on the fiscal year. While it contains financial data, it is an initial announcement of results (Earnings Release) rather than the full, audited Annual Report (10-K). It follows the standard format for an earnings release, providing key highlights and management's outlook. FY 2024
2025-02-03 French
2024 financial statements: significant reduction in net loss
Earnings Release Classification · 95% confidence The document is a press release from Global Bioenergies titled '2024 financial statements: significant reduction in net loss'. It provides a summary of financial highlights, including profit and loss accounts and balance sheet data for the fiscal year 2024. While it contains financial data, it is structured as a press release (announcing the approval of statements by the Board) rather than a full 10-K or formal annual report. According to the 'Menu vs Meal' rule, this is an initial announcement of financial results, which fits the definition of an Earnings Release (ER). FY 2024
2025-02-03 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.